---
title: "STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more"
description: "The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs"
author: "Ed Silverman"
section: health
published: 2026-10-06T13:32:22.002305+00:00
canonical: https://valorandventures.media/article/eca08074-fe50-4525-b22e-661081688788
publisher: "Valor & Ventures Media"
source: "STAT News"
source_url: https://www.statnews.com/pharmalot/2026/09/18/rules-for-china-licensing-deals-making-drugs-in-space/?utm_campaign=rss
access: free
---

# STAT+: Pharmalittle: We’re reading about licensing deals with China, making drugs in space, and more

*The U.S. is working on rules for investing in China that would likely preserve pharma's ability to strike most licensing deals for Chinese drugs*

## Article

---
Ed Silverman · STAT News · Photo: Alex Hogan/STAT

---

Originally published by STAT News: https://www.statnews.com/pharmalot/2026/09/18/rules-for-china-licensing-deals-making-drugs-in-space/?utm_campaign=rss